세계의 탈모증 시장 보고서(2025년)

Alopecia is a medical term describing the loss of hair, which can occur naturally, be associated with illnesses or the use of specific medications. It can manifest as localized or diffuse, temporary or permanent, and affect individuals of all ages and both genders. Treatment for alopecia aims to slow down, reverse, or manage hair loss and encourage regrowth in affected areas.

The primary types of alopecia include alopecia areata, androgenetic alopecia, alopecia totalis, traction alopecia, cicatricial alopecia, and others. Alopecia areata is an autoimmune condition characterized by sudden hair loss resulting in circular or oval patches on the scalp or other body areas. Various treatment options encompass pharmaceuticals, low-level laser therapy devices, hair transplants, regenerative medicine, and more. These treatments are available through diverse distribution channels like hospital pharmacies, retail pharmacies, online pharmacies, and others, catering to a wide range of end-users including dermatology clinics, home care settings, and more.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The alopecia market research report is one of a series of new reports from The Business Research Company that provides alopecia market statistics, including alopecia industry global market size, regional shares, competitors with an alopecia market share, detailed alopecia market segments, market trends and opportunities and any further data you may need to thrive in the alopecia industry. This alopecia market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The alopecia market size has grown steadily in recent years. It will grow from $11.08 billion in 2024 to $11.48 billion in 2025 at a compound annual growth rate (CAGR) of 3.6%. The growth in the historic period can be attributed to growing awareness of diagnosis, increasing consumer demand, increasing number of international medical tourism centers, improved reimbursement scenarios.

The alopecia market size is expected to see steady growth in the next few years. It will grow to $13.64 billion in 2029 at a compound annual growth rate (CAGR) of 4.4%. The growth in the forecast period can be attributed to increasing aging population, rising cosmetic concerns, increasing lifestyle factors, rising healthcare expenditure. Major trends in the forecast period include advancements in treatment options, biotechnological innovations, the growing use of artificial intelligence (AI) and machine learning (ML) in alopecia research.

The forecast of 4.4% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may pose a significant challenge for U.S. dermatology by restricting access to JAK inhibitor medications and laser therapy devices imported from Israel and Italy, potentially worsening hair regrowth outcomes and increasing trichology clinic expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The anticipated rise in the prevalence of hair loss is expected to drive the growth of the alopecia market in the coming years. Hair loss, characterized by the partial or complete loss of hair from its typical growth areas, is a condition that affects many individuals. Alopecia treatments play a crucial role in addressing various aspects of hair loss, including promoting hair regrowth, devising personalized treatment strategies, utilizing combination therapies, and managing the physical manifestations of hair loss. These interventions can significantly enhance an individual's emotional well-being and overall quality of life. For example, as of April 2023, data from the China-based National Health Commission indicates that over 250 million Chinese people have experienced hair loss, with 42% of them falling within the age range of 26 to 30. Additionally, data from the US-based Statistic Brain Research Institute in February 2023 reveals that approximately 40% of men will experience noticeable hair loss by the age of 35, and this percentage will increase to 65% by the age of 60. Hence, the growing prevalence of hair loss is a key driver behind the expansion of the alopecia market.

The substantial increase in government initiatives is poised to drive the growth of the alopecia market in the future. Government initiatives encompass specific actions, policies, programs, or projects undertaken by government authorities at various levels to address particular issues, achieve specific objectives, or enhance the overall well-being of their constituents and society as a whole. Government initiatives can significantly contribute to the advancement of alopecia treatment through various means, such as allocating funds for research, expediting the approval process for new drugs and therapies, and launching public awareness campaigns to educate both the public and healthcare professionals about alopecia. As an illustration, in June 2022, the Government of Ireland, as reported by gov.ie, introduced a new grant of $525.36 (€500) to assist individuals experiencing hair loss due to illness in covering the costs of wigs, hairpieces, or other hair replacements. Such initiatives can notably enhance the quality of life for those dealing with alopecia and related conditions. Consequently, the upsurge in government initiatives is a driving force behind the growth of the alopecia market.

Major companies operating in the alopecia market are focused on developing an innovative treatments to gain competitive advantages in the market. For instance, in June 2022, Eli Lilly and Company, a US-based pharmaceutical company and Incyte, a US-based pharmaceutical company, unveiled their approval for is luminant oral tablets by the United States Food and Drug Administration (FDA), a US-based federal agency. It is the first FDA-approved systemic treatment for treating severe alopecia areata in adults. Olumiant is also indicated for treating adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response to one or more tumor necrosis factor (TNF) blockers.

In March 2023, Sun Pharmaceutical Industries Limited, an India-based pharmaceutical company, acquired Concert Pharmaceuticals for $576 million. With this acquisition, Sun Pharmaceutical aims to improve and enhance its alopecia treatment offerings and expand its product portfolio. Concert Pharmaceuticals Inc. is a US-based biopharmaceutical company involved in developing oral inhibitors of Janus kinases as a treatment for alopecia areata.

Major companies operating in the alopecia market are Pfizer Inc., Johnson and Johnson Ltd., Merck and Co. Inc., Bayer AG, Novartis AG, Sanofi SA, GlaxoSmithKline PLC, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Allergan PLC, Teva Pharmaceutical Industries Ltd., Mylan N.V., Sun Pharmaceutical Industries Ltd., Perrigo Company PLC, Intertek Group PLC, Dr. Reddy's Laboratories Ltd., Cipla Limited, Almirall S.A., Aclaris Therapeutics Inc., Curallux LLC, Theradome Inc., Lexington International LLC, Histogen Inc., Apira Science Inc.

North America was the largest region in the alopecia market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the alopecia report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the alopecia market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The alopecia market consists of revenues earned by entities by providing anagen effluvium, telogen effluvium, and alopecia universalis treatments. The market value includes the value of related goods sold by the service provider or included within the service offering. The alopecia market also includes the sales of shampoos, drugs, and hair regrowth supplements. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Alopecia Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on alopecia market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for alopecia ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The alopecia market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Alopecia Areata; Androgenetic Alopecia; Alopecia Totalis; Traction Alopecia; Cicatricial Alopecia; Other Types
• 2) By Treatment: Pharmaceutical; Low Level Laser Therapy (LLLT) Devices; Hair Transplant; Regenerative Medicine; Other Treatments
• 3) By Gender: Male; Female
• 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Other Distribution Channels
• 5) By End-User: Dermatology Clinics; Homecare Settings; Other End-Users
• Subsegments:
• 1) By Alopecia Areata: Patchy Alopecia Areata; Persistent Patchy Alopecia Areata; Alopecia Universalis; Diffuse Alopecia Areata; Ophiasis
• 2) By Androgenetic Alopecia: Male Pattern Baldness; Female Pattern Hair Loss
• 3) By Alopecia Totalis: Complete Scalp Hair Loss
• 4) By Traction Alopecia: Frontal Traction Alopecia; Occipital Traction Alopecia
• 5) By Cicatricial Alopecia: Lichen Planopilaris; Discoid Lupus Erythematosus; Central Centrifugal Cicatricial Alopecia; Frontal Fibrosing Alopecia; Folliculitis Decalvans
• 6) By Other Types: Telogen Effluvium; Anagen Effluvium; Trichotillomania
• Companies Mentioned: Pfizer Inc.; Johnson and Johnson Ltd.; Merck and Co. Inc.; Bayer AG; Novartis AG; Sanofi SA; GlaxoSmithKline Plc; Eli Lilly and Company; Boehringer Ingelheim International GmbH; Allergan Plc; Teva Pharmaceutical Industries Ltd.; Mylan N.V.; Sun Pharmaceutical Industries Ltd.; Perrigo Company Plc; Intertek Group Plc; Dr. Reddy's Laboratories Ltd.; Cipla Limited; Almirall S.A.; Aclaris Therapeutics Inc.; Curallux LLC; Theradome Inc.; Lexington International LLC; Histogen Inc.; Apira Science Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Alopecia Market Characteristics

3. Alopecia Market Trends And Strategies

4. Alopecia Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Alopecia Growth Analysis And Strategic Analysis Framework

• 5.1. Global Alopecia PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Alopecia Market Growth Rate Analysis
• 5.4. Global Alopecia Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Alopecia Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Alopecia Total Addressable Market (TAM)

6. Alopecia Market Segmentation

• 6.1. Global Alopecia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Alopecia Areata
• Androgenetic Alopecia
• Alopecia Totalis
• Traction Alopecia
• Cicatricial Alopecia
• Other Types
• 6.2. Global Alopecia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceutical
• Low Level Laser Therapy (LLLT) Devices
• Hair Transplant
• Regenerative Medicine
• Other Treatments
• 6.3. Global Alopecia Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Male
• Female
• 6.4. Global Alopecia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Other Distribution Channels
• 6.5. Global Alopecia Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Dermatology Clinics
• Homecare Settings
• Other End-Users
• 6.6. Global Alopecia Market, Sub-Segmentation Of Alopecia Areata, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Patchy Alopecia Areata
• Persistent Patchy Alopecia Areata
• Alopecia Universalis
• Diffuse Alopecia Areata
• Ophiasis
• 6.7. Global Alopecia Market, Sub-Segmentation Of Androgenetic Alopecia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Male Pattern Baldness
• Female Pattern Hair Loss
• 6.8. Global Alopecia Market, Sub-Segmentation Of Alopecia Totalis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Complete Scalp Hair Loss
• 6.9. Global Alopecia Market, Sub-Segmentation Of Traction Alopecia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Frontal Traction Alopecia
• Occipital Traction Alopecia
• 6.10. Global Alopecia Market, Sub-Segmentation Of Cicatricial Alopecia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Lichen Planopilaris
• Discoid Lupus Erythematosus
• Central Centrifugal Cicatricial Alopecia
• Frontal Fibrosing Alopecia
• Folliculitis Decalvans
• 6.11. Global Alopecia Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Telogen Effluvium
• Anagen Effluvium
• Trichotillomania

7. Alopecia Market Regional And Country Analysis

• 7.1. Global Alopecia Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Alopecia Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Alopecia Market

• 8.1. Asia-Pacific Alopecia Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Alopecia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Alopecia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Alopecia Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Alopecia Market

• 9.1. China Alopecia Market Overview
• 9.2. China Alopecia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Alopecia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Alopecia Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Alopecia Market

• 10.1. India Alopecia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Alopecia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Alopecia Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Alopecia Market

• 11.1. Japan Alopecia Market Overview
• 11.2. Japan Alopecia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Alopecia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Alopecia Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Alopecia Market

• 12.1. Australia Alopecia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Alopecia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Alopecia Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Alopecia Market

• 13.1. Indonesia Alopecia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Alopecia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Alopecia Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Alopecia Market

• 14.1. South Korea Alopecia Market Overview
• 14.2. South Korea Alopecia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Alopecia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Alopecia Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Alopecia Market

• 15.1. Western Europe Alopecia Market Overview
• 15.2. Western Europe Alopecia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Alopecia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Alopecia Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Alopecia Market

• 16.1. UK Alopecia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Alopecia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Alopecia Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Alopecia Market

• 17.1. Germany Alopecia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Alopecia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Alopecia Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Alopecia Market

• 18.1. France Alopecia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Alopecia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Alopecia Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Alopecia Market

• 19.1. Italy Alopecia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Alopecia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Alopecia Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Alopecia Market

• 20.1. Spain Alopecia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Alopecia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Alopecia Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Alopecia Market

• 21.1. Eastern Europe Alopecia Market Overview
• 21.2. Eastern Europe Alopecia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Alopecia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Alopecia Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Alopecia Market

• 22.1. Russia Alopecia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Alopecia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Alopecia Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Alopecia Market

• 23.1. North America Alopecia Market Overview
• 23.2. North America Alopecia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Alopecia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Alopecia Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Alopecia Market

• 24.1. USA Alopecia Market Overview
• 24.2. USA Alopecia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Alopecia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Alopecia Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Alopecia Market

• 25.1. Canada Alopecia Market Overview
• 25.2. Canada Alopecia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Alopecia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Alopecia Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Alopecia Market

• 26.1. South America Alopecia Market Overview
• 26.2. South America Alopecia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Alopecia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Alopecia Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Alopecia Market

• 27.1. Brazil Alopecia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Alopecia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Alopecia Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Alopecia Market

• 28.1. Middle East Alopecia Market Overview
• 28.2. Middle East Alopecia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Alopecia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Alopecia Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Alopecia Market

• 29.1. Africa Alopecia Market Overview
• 29.2. Africa Alopecia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Alopecia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Alopecia Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Alopecia Market Competitive Landscape And Company Profiles

• 30.1. Alopecia Market Competitive Landscape
• 30.2. Alopecia Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson and Johnson Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck and Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

31. Alopecia Market Other Major And Innovative Companies

• 31.1. Sanofi SA
• 31.2. GlaxoSmithKline Plc
• 31.3. Eli Lilly and Company
• 31.4. Boehringer Ingelheim International GmbH
• 31.5. Allergan Plc
• 31.6. Teva Pharmaceutical Industries Ltd.
• 31.7. Mylan N.V.
• 31.8. Sun Pharmaceutical Industries Ltd.
• 31.9. Perrigo Company Plc
• 31.10. Intertek Group Plc
• 31.11. Dr. Reddy's Laboratories Ltd.
• 31.12. Cipla Limited
• 31.13. Almirall S.A.
• 31.14. Aclaris Therapeutics Inc.
• 31.15. Curallux LLC

32. Global Alopecia Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Alopecia Market

34. Recent Developments In The Alopecia Market

35. Alopecia Market High Potential Countries, Segments and Strategies

• 35.1 Alopecia Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Alopecia Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Alopecia Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer